BONE MARROW FAILURE
Clinical trials for BONE MARROW FAILURE explained in plain language.
Never miss a new study
Get alerted when new BONE MARROW FAILURE trials appear
Sign up with your email to follow new studies for BONE MARROW FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
‘Veto’ cells could make stem cell transplants safer for blood cancer patients
Disease control OngoingThis early-phase study tests whether adding specially treated immune cells (called veto cells) from a donor can help stem cell transplants work better in people with blood cancers like leukemia or lymphoma. The goal is to help the donor cells grow without causing severe graft-ver…
Matched conditions: BONE MARROW FAILURE
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New gene therapy aims to fix bone marrow in rare telomere disease
Disease control OngoingThis early-phase study tests a new treatment called EXG34217 in 12 people aged 12 and older who have bone marrow failure due to telomere biology disorders. The main goal is to see if the treatment is safe and tolerable. Researchers will also check if it improves blood cell counts…
Matched conditions: BONE MARROW FAILURE
Phase: PHASE1 • Sponsor: Elixirgen Therapeutics, Inc. • Aim: Disease control
Last updated May 01, 2026 15:58 UTC